Mediclinic International plc, commonly known as Mediclinic, is a leading private healthcare group headquartered in South Africa (ZA). Established in 1983, the company operates a network of hospitals and clinics across Southern Africa, the Middle East, and Switzerland, providing high-quality medical services. Specialising in acute care, rehabilitation, and outpatient services, Mediclinic is renowned for its commitment to patient safety and clinical excellence. The group has achieved significant milestones, including the integration of advanced technology and a focus on specialised medical fields, which sets it apart in the competitive healthcare landscape. With a strong market position, Mediclinic has been recognised for its innovative healthcare solutions and exceptional patient care, making it a trusted name in the industry.
How does Mediclinic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Mediclinic's score of 35 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Mediclinic reported total carbon emissions of approximately 182,898,000 kg CO2e from Scope 1 and 2, alongside 117,128,000 kg CO2e from Scope 3 emissions. This data reflects a commitment to transparency in their environmental impact, with a focus on reducing their carbon footprint across all scopes. Mediclinic has set ambitious climate commitments, aiming to achieve carbon neutrality by 2030. This target encompasses all scopes of emissions, demonstrating a comprehensive approach to sustainability. The organisation has also pledged to eliminate waste sent to landfills by the same year, reinforcing its dedication to environmental stewardship. The emissions data is sourced directly from Mediclinic Group Limited, ensuring accuracy and accountability in their reporting. As part of their ongoing efforts, Mediclinic is actively working towards these reduction targets, which are crucial for aligning with global climate goals.
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 19,664,000 | 00,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - | - | - | - | - |
| Scope 2 | 154,298,000 | 000,000,000 | 000,000 | 000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | - | - |
| Scope 3 | - | - | 0,000 | 000,000 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mediclinic has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
